Aurisco Pharmaceutical Co.,Ltd.
SHH: 605116.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dingjun Chu
- Employees
- 1,521
- Headquarters
- Tiantai, China
- IPO year
- 2020
- Market cap
- CN¥9.3B
- Website
- https://www.aurisco.com
Loading 605116…
Loading profile data…Frequently asked questions about 605116
What does Aurisco Pharmaceutical Co.,Ltd. (605116.SS) do?
Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing...
Where does 605116.SS trade?
Aurisco Pharmaceutical Co.,Ltd. (605116.SS) trades on the Shanghai Stock Exchange.
What sector is 605116.SS in?
Aurisco Pharmaceutical Co.,Ltd. (605116.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aurisco Pharmaceutical Co.,Ltd.?
Dingjun Chu is the chief executive officer of Aurisco Pharmaceutical Co.,Ltd. (605116.SS).
Where is Aurisco Pharmaceutical Co.,Ltd. headquartered?
Aurisco Pharmaceutical Co.,Ltd. is headquartered in China.
Does 605116.SS pay a dividend?
Yes — Aurisco Pharmaceutical Co.,Ltd. (605116.SS) paid a trailing twelve-month dividend of CNY 0.29 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 605116.SS go public?
Aurisco Pharmaceutical Co.,Ltd. (605116.SS) completed its initial public offering in 2020.